As of 2025-12-21, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 487.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.72 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 7161.8%.
The range of the Relative Valuation is 340.59 - 563.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.6x - 37.7x | 36.4x |
| Forward P/E multiples | 22.9x - 32.8x | 29.0x |
| Fair Price | 340.59 - 563.13 | 487.99 |
| Upside | 4968.3% - 8279.9% | 7161.8% |
| Date | P/E |
| 2025-12-19 | 0.45 |
| 2025-12-18 | 0.44 |
| 2025-12-17 | 0.42 |
| 2025-12-16 | 0.43 |
| 2025-12-15 | 0.44 |
| 2025-12-12 | 0.44 |
| 2025-12-11 | 0.45 |
| 2025-12-10 | 0.45 |
| 2025-12-09 | 0.45 |
| 2025-12-08 | 0.45 |
| 2025-12-05 | 0.45 |
| 2025-12-04 | 0.45 |
| 2025-12-03 | 0.45 |
| 2025-12-02 | 0.45 |
| 2025-12-01 | 0.45 |
| 2025-11-28 | 0.46 |
| 2025-11-26 | 0.45 |
| 2025-11-25 | 0.44 |
| 2025-11-24 | 0.44 |
| 2025-11-21 | 0.42 |
| 2025-11-20 | 0.42 |
| 2025-11-19 | 0.43 |
| 2025-11-18 | 0.43 |
| 2025-11-17 | 0.43 |
| 2025-11-14 | 0.44 |
| 2025-11-13 | 0.44 |
| 2025-11-12 | 0.46 |
| 2025-11-11 | 0.47 |
| 2025-11-10 | 0.48 |
| 2025-11-07 | 0.47 |
| 2025-11-06 | 0.46 |
| 2025-11-05 | 0.46 |
| 2025-11-04 | 0.46 |
| 2025-11-03 | 0.47 |
| 2025-10-31 | 0.47 |
| 2025-10-30 | 0.47 |
| 2025-10-29 | 0.47 |
| 2025-10-28 | 0.46 |
| 2025-10-27 | 0.46 |
| 2025-10-24 | 0.45 |
| 2025-10-23 | 0.44 |
| 2025-10-22 | 0.44 |
| 2025-10-21 | 0.44 |
| 2025-10-20 | 0.44 |
| 2025-10-17 | 0.44 |
| 2025-10-16 | 0.44 |
| 2025-10-15 | 0.45 |
| 2025-10-14 | 0.45 |
| 2025-10-13 | 0.45 |
| 2025-10-10 | 0.45 |